On ECHEMI
Home > Drugs > Malignant hypertensive retinopathy
Malignant hypertensive retinopathy
Malignant hypertensive retinopathy is a sudden and sharp increase in blood pressure in a short period of time, which causes retinal and choroidal vascular decompensation, significant narrowing of retinal blood vessels, widespread retinal edema, multiple patchy hemorrhages, large cotton wool spots and optic disc edema in the fundus.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    Young and middle-aged people, patients with hypertension
  • Related symptoms:

    Retinal edema outpatient hypertension retinal hemorrhage increased intracranial pressure nausea
  • Concurrent disease:

Related Drugs
Vitamin E, C granules
Indication: It is used to prevent and treat diseases caused by vitamin E and vitamin C deficiency, such as scurvy, and the recovery period and wound healing period after various acute and chronic infectious diseases or other diseases. It can also be used as an auxiliary treatment for allergic diseases, cardiovascular and cerebrovascular diseases, habitual abortion, infertility and skin pigmentation.
Manufacturer:

Hunan Kanerga Pharmaceutical Co., Ltd.

Compound Triazine Rutin Tablets
Indication: Used for early and mid-stage hypertension.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.